APPENDIX A:

Drug Study

Patient: M.R.C. Age: 16 Hospital No.: 11256-2010 Room No.: Ward 1-Bed 11
Impression/ Diagnosis: PUFT cephalic female live birth secondary to CPD Attending Physician: Dr. Maglasang
Allergy to: NONE

Generic Name & Dose, Strength, Indication/ Adverse/ Side Effects Nursing Rationale Client
Brand Name &Formulation Mechanism of Drug Interaction Responsibilities Teaching
Action

Generic: Ordered: Indications: Adverse Reactions: Assessment:

Cefuroxime Give Cefuroxime
Sodium 750 mg IVTT  Perioperative  CNS: dizziness,  Asses patient’s  To establish  Instruct the
every 8 hrs. prevention. headache, malaise, infection before good baseline patient to take
ANST  Uncomplicated paresthesia. therapy and data regarding the drug
skin and skin  GI: abdominal regularly patient’s exactly as
Brand: Timing: structure cramps, diarrhea thereafter. condition. prescribed,
Zinacef Every 8 hrs. infection.  HEMATOLOGIC:  Before giving  To confirm even of he feels
 Uncomplicated eosinophilia, first dose, obtain accurately if better.
Duration: UTI. haemolytic anemia, specimen for patient is not  Advise patient
18-24 hrs.  Uncomplicated transient culture and allergic to the to take oral
gonorrhoea. neutropenia sensitivity tests. medication. suspension
 Otitis media.  RESPIRATORY: Begin therapy with food to
Other forms: dyspnea pending test enhance
 Infusion: Mechanisms of  SKIN: results. absorption.
750 mg, 1.5 g Action: erythematous  Assess patient’s  For the family  Explain that
premixed, rashes, urticuria and family’s to acquire tablets may be
frozen solution  Chemical Effect:  OTHERS: knowledge of knowledge of crushed, but
- Inhibits hypersensitivity drug therapy. the appropriate drug has bitter
 Injection: cell-wall reactions, pain actions and tastes.
750 mg, 1.5 g synthesis, interventions.  Tell the patient
promoting to report any
osmotic adverse
instability , reactions.
 usually Nursing
bacteriocidal Interactions: Diagnosis:
 Drug – Drug:  Ineffective
 Therapeutic - Diuretics: protection R/T
Effect: may increase bacteria
- Hinders or risk of susceptible to
kills adverse renal drug.
susceptible reactions.  Risk for
bacteria Monitor renal deficient fluid
including function volume R/T
many gram- closely. drug adverse
positive  Drug- Food: GI reactions.
organisms May increase  Deficient
and enteric drug absorption knowledge R/T
gram- and drug therapy.
negative bioavailability
bacilli. of suspension.

Generic: Ordered: Indications: Adverse Reactions: Assessment:

Celecoxib Give celecoxib  Relief of signs  CNS: dizziness,  Assess patient  To be able to  Instruct patient
200 mg 1 tab. and symptoms of headache, for have a good to immediately
osteoarthritis. insomnia. appropriateness baseline data. report any
Brand: Timing:  Acute pain and  CV: hypertension of therapy. signs of GI
Celebrex BID primary  EENT: pharyngitis,  Monitor patient  To be able to bleeding.
dysmenorrhea. rhinitis, sinusitis. for evidence of conduct  Advise patient
Other forms:  Relief of signs  G I: abdominal occult bleeding. appropriate to report
 Capsules: and symptoms of pain, diarrhea, measures. immediately
50 mg, 100 rheumatoid dyspensia.  Monitor patient  To be able to rash,
mg, 200 mg, arthritis.  METABOLIC: for signs and assess the level unexplained
400 mg hyperchloremia, symptoms of of toxicity the weight gain or
hypophosphatemia. hepatomegaly. drug have to the edema.
patient.  Instruct to take
drug with
food.
 Mechanisms of  MUSCULOSKEL Nursing
Action: ETAL: Diagnosis:
back pain
 Chemical effect:  RESPIRATORY:  Acute pain R/T
- May upper respiratory underlying
selectively tract infection. infection.
inhibit  SKIN:  Risk for injury
COX2, Erythema, rash. R/T drug-
decreasing  OTHERS: induced adverse
prostaglandi accidental injury. reactions.
ne synthesis.  Deficient
 Therapeutic knowledge R/T
effect: Interactions: therapy.
- Relieves  Drug- Drug:
pain and - Aspirin:
inflammatio May increase
n in joints risk of ulcers.
and smooth - Fluconazole:
muscle May increase
tissue. celecoxib level.
 Drug- Lifestyle:
- Chronic
alcoholic use
smoking; may
increase risk
for GI
irritation or
bleeding.
Generic: Ordered: Indications: Adverse Reactions: Assessment:
Gentamicin Give Gentamicin  Meningitis  CNS: headache,  Assesse  To be able to  Instruct patient
Sulfate 80 mg IVTT patient’s provide a good to notify
lethargy, numbmess
every 8 hrs. infection and baseline data. prescribier
ANST hearing before about adverse
therapy. reactions.
Brand: Timing:  Endocarditis  EENT: ototoxicity  Obtain specimen  To be able to  Emphasizes
AgentAmp-amp Every 8 hrs. ANST prophylaxis for GI  GU: nephrotoxicity For culture abd confirm if importance of
Bellagen-vial or GU procedure  HEMATOLOGY: sensitivity tests patient have drinking at
Elin Gentamicin- Duration: or surgery. agranulocytosis, before giving the other problems least 2L of
amp 7-12 days  Posthemodialysis leukopenia, first dose. that may result. fluids daily, it
Garemycin to maintain thrombocytopenia.  Be alert for  To be able to not
Cream Other forms: therapeutic level.  OTHER: adverse provide contraindicated
Gentrolex-vial  Injection: hypersensitivity reactions and appropriate .
RiteMed 40 Mechanism of reactions. drug measures.
Gentamicin-vial mg/mL(adult) Action: interactions.
10mg/mL(pedia)  Chemical effect: Interactions:  Assess patient’s  For the patient
 IV infusion - Inhibits  Drug-Drug and family’s and the family
premixed: protein - Atrocurium: knowledge of to acquire
40mg, 60 mg, synthesis by may increase therapy. knowledge.
70mg, 80 mg, binding to neutomuscula
90mg, 100 mg, ribosomes. r blockade. Nursing
120mg, 160 mg,  Therapeutic - Cephalothin: Diagnosis:
180mg Effect: may increase  Risk for
- Kills nephrotoxicit infection R/T
susceptible y. presence of
bacteria. - Diuretics: susceptible
Drug only may increase bacteria.
may act ototoxicity.  Impaired
against urinary
some elimination R/T
aminoglycos nephrotoxicity.
ide-resistant  Deficient
bacteria. knowledge R/T
drug therapy.

Generic: Ordered: Indications: Adverse Reactions: Assessment:

Metronidazole Give  Amebic hepatic  CNS: ataxia,  To monitor  Tell patient to
Assess patient
hydrochloride metronidazole 80 abscess. confusion,depressio drug’s effect. avoid alcohol
infection before
mg IVTT every n. therapy. or drugs.
8hrs. ANST.
Brand: Timing:  Intestinal  CV: edema,  Watch  To monitor  Instruct
Flagel IV RTU Every 8 hrs. amebiasis. flattened T wave, carefully for sodium patient to take
Metro IV  Pelvic flushing edema. retention. oral form with
Novonidazol Duration; inflammatory  EENT: eye tearing.  Be alert for  To establish meal to
1-2 hrs. disease.  GI: abdominal adverse proper minimize
 Bacterial cramping, reactions. precautionary reactions.
Other forms; vaginosis. anorexia, measures for  Instruct
 Capsule: 375 mg constipation. possible patient in
 Injection: Mechanism of  GU: cystitis, Nursing adverse effects. proper
5mg/mL Actions: darkened urine, dry Diagnosis; hygiene.
 Tablets: 250 mg ,  Chemical Effects: vagina.  Teach patient
500mg - Direct  HEMATOLOGIC:  Risk for to cleanse
 Tablets(extended acting neutropenia, infection R/T affected areas
release): 750 mg trichomacid thrombocytopenia, presence of twice daily
e and transient leukymia. susceptible before
amebicide  SKIN: burning and organisms. applying
that works stinging, contact  Risk for MetroLotion.
at both dermatitis, dry deficient fluid
intestinal skin. volume R/T
and  OTHERS: drug- induced
extraintestin decreased libido, adverse GI
al sites. glossitis, reactions.
 Therapeutic gynecomastia.  Deficient
Effects: knowledge
- Hinders Interactions: R/T drug
growth of  Drug-Drug therapy.
selected - Disulfiram:
organisms. may cause
acute
psychosis and
confusion.
- Lithium: may
increase
lithium level
resulting in
toxicity.
  Drug- Lifestyle;
- Alcohol
use: may
cause
disulfira
m like
reactions.

Generic: Ordered: Indications: Adverse Reactions: Assessment:

Paracetamol Give Paracetamol  Mild fever or  HEMATOLOGIC  Assess  To be able to  Tell the
1 amp every 4 hrs pain. : patient’s pain establish a patient not to
PRN for fever.  Osteoarthritis hemolytic or temperature good baseline use drug for
Brand: anemia, before giving data of the fever higher
Abenol Timing: leukopenia, the therapy. patient. than 39.5ºC.
FeverAll infant Every 4 hrs PRN Mechanism of neutropenia  Be alert for  To establish  Warn patient
Mapap Actions:  HEPATIC: liver adverse the most that high
Tylenol Duration: damage, jaundice reactions and appropriate doses of
Aceta Elixir 4-6 hrs.  Chemical  METABOLIC: drug measures. unsupervised
Tempra Effects; hypoglycaemia interactions long-term use
Biogesic Other forms: - Blocks  SKIN: urticaria . can cause liver
 Capsules: pain’s  Provide TSB  To lessen the damage.
500mg impulses, patient’s  Tell patient
 Gelcaps: 500mg probably by Interactions; Nursing temperature. not to exceed
 Liquid: inhibiting  Drug-Drug: Diagnosis: total
160mg/5ml, prostaglandi - Lamotrig recommended
500mg/15ml n or pain ine:  Acute pain dose of
 Solution: 80mg/ receptor serum R/T patient’s acetaminophe
1.66ml, sensitizers. lamotrigi underlying n per day
100mg/ml ne condition. because of
concentra risk of
tion may hepatotoxicit.
be  Tell a breast-
reduced feeding
and mother about
the drug.
  Tablets: 160  Therapeutic may decrease  Risk for
mg, 325mg, Effects: therapeutic injury R/T
500mg, 650 - Relieves effect. drug induced
mg pain and - Warfarin: may liver damage
reduces increase with toxic
fever. hypoprothrom doses.
binemic effect  Deficient
with long knowledge
lasting use of R/T therapy.
acetaminophe
n.

Generic: Ordered: Indications: Adverse Reactions: Assessement:

Retinol (Vitamin Give Vit. A 4 cups  RDA  CNS: fatigue,  Assess  To monitor  Warn patient
A) 5000u OD  Sever Vitamin A headache, patient’s drug’s in taking
Deficiency irritability vitamin A effectiveness. mega doses
Brand: Timing:  Maintenance  EENT: intake.  To be able to of vitamin A
Aquasol A, OD dosage to exopthalmos,  If dose are have the without
Palmitate-A prevent papilledema high watch appropriate specific
5000 Duration: recurrence of  GI: anorexia, for adverse measures to do. indications.
3-5 hrs vitamin A epigastric pain, reactions.  To be able to  Explain
deficiency. polydipsia. conclude if importance
Other forms:  GU:  Assess significant of avoiding
 Capsules: 10000 Mechanism of hypomenorrhea, patient’s and others and the prolonged
IU, 15000IU, Action: polyuria. family’s patient was use of
25000IU,  Chemical  HEPATIC: knowledge of able to gain mineral oil
50000IU effects: cirrhosis, therapy. knowledge. while taking
hepatomegaly the drug.
 Injection: 2- - Stimulates  MUSCULOSKELET  Instruct
mL vials retinal AL: cortical patient to
thickening over the Nursing sort vitamin
function, radius and tibia, Diagnosis: A in tight
 Tablets: 5000 bone growth, decalcification of container.
IU reproduction. bone.  Imbalanced
 Therapeutic Effects:  SKIN: alopecia, dry, nutrition: less
- Raises cracked, skin, than body
vitamin A inflamed tongue. requirement
level in body. R/T
 OTHER: inadequate
anaphylactic shock intake.
 Ineffective
Interactions: health
Drug- Drug; maintenance
- Cholestyrami R/T vitamin A
ne resin: may toxicity caused
decrease GI by excessive
absorption of intake.
fat-soluble  Deficient
vitamins. knowledge
- Hormonal R/T drug
contraceptive therapy.
s: may
increase
vitamin A
level.
- Neomycin:
may decrease
vitamin A
level.